India’s Zydus Lifesciences is in the FDA’s crosshairs once again, this time for a trio of unnamed violations at an injectables facility. Following an FDA inspection that wrapped up this week, Zydus, ...
New Delhi, May 10 (PTI) Zydus Cadila has received final approval from the US health regulator to market Carbidopa tablets, used for treating symptoms of Parkinson’s disease. Parkinson’s symptoms ...
Zydus Lifesciences continues to be under intense scrutiny from the FDA, which hit the Indian drugmaker’s production facility in Jarod with a warning letter. Earlier this year, Zydus was slammed within ...
Zydus Lifesciences Limited announced on March 11, 2025, that it entered into an agreement to acquire a majority stake in Amplitude Surgical. Reports state that Zydus Lifesciences has a tender offer ...
AHMEDABAD, India--(BUSINESS WIRE)--Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and ...
Abbott gets right to at least 24 Zydus products Abbott to commercialize products in 15 emerging markets May 11 (Reuters) - Abbott Laboratories Inc said it entered into a licensing agreement to ...
Zydus to launch Semaglutide Injection in India, featuring a unique reusable pen for improved diabetes and obesity management.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results